{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:18:17Z","timestamp":1790266697129,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1996,3,1]],"date-time":"1996-03-01T00:00:00Z","timestamp":825638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[1996,3]]},"DOI":"10.1007\/s002800050410","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T08:03:26Z","timestamp":1030262606000},"page":"445-450","source":"Crossref","is-referenced-by-count":23,"title":["Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabine"],"prefix":"10.1007","volume":"37","author":[{"given":"L. E.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. W.","family":"Denny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. O.","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Plunkett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"60370445280_CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0609.1990.tb00345.x","volume":"44","author":"A Apostolopoulos","year":"1990","unstructured":"Apostolopoulos A, Symeonidis A, Zoumbos N (1990) Prognostic significance of immune function parameters in patients with chronic lymphocytic leukaemia. Eur J Haematol 44:39","journal-title":"Eur J Haematol"},{"key":"60370445280_CR2","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.134.4.2783","volume":"134","author":"T Barlozzari","year":"1985","unstructured":"Barlozzari T, Leonhardt J, Wiltrout RH, Herberman RB, Reynolds CW (1985) Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J Immunol 134:2783","journal-title":"J Immunol"},{"key":"60370445280_CR3","first-page":"4661","volume":"44","author":"DH Boldt","year":"1984","unstructured":"Boldt DH, Von Hoff DD, Kuhn JG, Hersh M (1984) Effects on human peripheral lymphocytes of in vivo administration of 9-\u03b2-D-arabinofuranosyl-2-fluoroadenine-5\u2032-monophosphate (NSC 31887), a new purine antimetabolite. Cancer Res 44:4661","journal-title":"Cancer Res"},{"key":"60370445280_CR4","first-page":"18295","volume":"51","author":"CV Catapano","year":"1991","unstructured":"Catapano CV, Chandler K, Fernandes DJ (1991) Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate. Cancer Res 51:18295","journal-title":"Cancer Res"},{"key":"60370445280_CR5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.2830290307","volume":"29","author":"BD Cheson","year":"1988","unstructured":"Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Schiffer CA, Oken MM, Keating MJ, Bolt DH, Kempin SJ, Foon KA (1988) Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-Sponsored Working Group. Am J Hematol 29:152","journal-title":"Am J Hematol"},{"key":"60370445280_CR6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2141.1984.tb03998.x","volume":"58","author":"R Foa","year":"1984","unstructured":"Foa R, Lauria F, Lusso P, Guibellino MC, Fierro MT, Ferrando ML (1984) Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia. Br J Haematol 58:509","journal-title":"Br J Haematol"},{"key":"60370445280_CR7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2141.1986.tb02911.x","volume":"62","author":"R Foa","year":"1986","unstructured":"Foa R, Fierro MT, Lusso P, Raspadori D, Ferrando ML, Matera L, Malavasi F, Lauria F (1986) Reduced natural killer T-cells in B-cell chronic lymphocytic leukaemia identified by three monoclonal antibodies: Leu-11, A10, AB8.28. Br J Haematol 62:151","journal-title":"Br J Haematol"},{"key":"60370445280_CR8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(72)92345-8","volume":"2","author":"ER Giblett","year":"1972","unstructured":"Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ (1972) Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2:1067","journal-title":"Lancet"},{"key":"60370445280_CR9","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.4049\/jimmunol.127.5.1754","volume":"127","author":"N Hanna","year":"1981","unstructured":"Hanna N, Burton RC (1981) Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastasis in vivo. J Immunol 127:1754","journal-title":"J Immunol"},{"key":"60370445280_CR10","doi-asserted-by":"crossref","first-page":"16617","DOI":"10.1016\/S0021-9258(17)46267-3","volume":"265","author":"P Huang","year":"1990","unstructured":"Huang P, Chubb S, Plunkett W (1990) Termination of DNA synthesis by 9-\u03b2-D-arabinofuranosyl-2-fluoroadenine J Biol Chem 265:16617","journal-title":"J Biol Chem"},{"key":"60370445280_CR11","first-page":"1410","volume":"48","author":"MJ Humphries","year":"1988","unstructured":"Humphries MJ, Matsumoto K, White SL, Molyneux RJ, Olden K (1988) Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator. Cancer Res 48:1410","journal-title":"Cancer Res"},{"key":"60370445280_CR12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0272-2712(18)30704-2","volume":"8","author":"NE Kay","year":"1988","unstructured":"Kay NE, Perri RT (1988) Immunobiology of malignant B-cells and immunoregulatory cells in B-chronic lymphocytic leukemia. Clin Lab Med 8:163","journal-title":"Clin Lab Med"},{"key":"60370445280_CR13","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1182\/blood.V73.4.1016.1016","volume":"73","author":"NE Kay","year":"1989","unstructured":"Kay NE, Perri RT (1989) Evidence that large granular lymphocytes from B-CLL patients with hypogammaglobulinemia down-regulate B-cell immunoglobulin synthesis. Blood 73:1016","journal-title":"Blood"},{"key":"60370445280_CR14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ajh.2830240207","volume":"24","author":"NE Kay","year":"1985","unstructured":"Kay NE, Zarling J (1985) Restoration of impaired natural killer cell activity of B-chronic lymphocytic leukemia patients by recombinant interleukin-2. Am J Hematol 24:161","journal-title":"Am J Hematol"},{"key":"60370445280_CR15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood.V74.1.19.bloodjournal74119","volume":"74","author":"MJ Keating","year":"1989","unstructured":"Keating MJ, Kantarjian H, Talpaz M, Redman J, Koller C, Barlogie B, Velasquez W, Plunkett W, Freireich EJ, McCredie K (1989) Fludarabine: A new agent with major activity against chronic lymphocytic leukemia. Blood 74:19","journal-title":"Blood"},{"key":"60370445280_CR16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1200\/JCO.1991.9.1.44","volume":"9","author":"MJ Keating","year":"1991","unstructured":"Keating MJ, Kantarjian H, O\u2019Brien S, Koller C, Talpaz M, Schachner J, Childs CC, Freireich EJ, McCredie KB (1991) Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. J Clin Oncol 9:44","journal-title":"J Clin Oncol"},{"key":"60370445280_CR17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/B978-0-12-341370-3.50044-0","volume-title":"Mechanism of cytotoxicity by NK cells","author":"K Kumagai","year":"1985","unstructured":"Kumagai K, Suzuki S, Arai S (1985) Immunoregulatory effects of NK cells. In: Herberman RB, Callewaert DM (eds) Mechanism of cytotoxicity by NK cells. Academic Press, New York, p 489"},{"key":"60370445280_CR18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1600-0609.1994.tb01279.x","volume":"52","author":"F Lauria","year":"1994","unstructured":"Lauria F, Rondelli D, Raspadori D, Benfenati D, Tura S (1994) Rapid restoration of natural killer activity following treatment with 2-chlorodeoxyadenosine in 22 patients with hairy-cell leukemia. Eur J Haematol 52:16","journal-title":"Eur J Haematol"},{"key":"60370445280_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0162-3109(87)90024-5","volume":"13","author":"RW Luebke","year":"1987","unstructured":"Luebke RW, Lawson LD, Rogers RR, Riddle MM, Rowe DG, Smialowicz RJ (1987) Selective immunotoxic effects in mice treated with the adenosine deaminase inhibitor 2\u2019-deoxycoformycin. Immunopharmacology 13:25","journal-title":"Immunopharmacology"},{"key":"60370445280_CR20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/07328318908054199","volume":"8","author":"JA Nelson","year":"1989","unstructured":"Nelson JA, Richie ER, Kandil O, Vidale E, Pan BF (1989) Differential sensitivities of normal and malignant murine lymphocytes to purine nucleosides. Nucleosides Nucleotides, 8:569","journal-title":"Nucleosides Nucleotides"},{"key":"60370445280_CR21","first-page":"485","volume":"34","author":"WB Parker","year":"1988","unstructured":"Parker WB, Bapat AR, Shen JX, Townsend AJ, Cheng YC (1988) Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerase, DNA primase, and ribonucleotide reductase. Mol Pharmacol 34:485","journal-title":"Mol Pharmacol"},{"key":"60370445280_CR22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ajh.2830310305","volume":"31","author":"RT Perri","year":"1989","unstructured":"Perri RT, Kay NE (1989) Large granular lymphocytes from B-chronic lymphocytic leukemia patients inhibit normal B cell proliferation. Am J Hematol 31:166","journal-title":"Am J Hematol"},{"key":"60370445280_CR23","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.4049\/jimmunol.125.3.1216","volume":"125","author":"CD Platsoucas","year":"1980","unstructured":"Platsoucas CD, Fernandes G, Gupta SL, Kempin S, Clarkson B, Good RA, Gupta S (1980) Defective spontaneous and antibodydependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vivo treatment with interferon. J Immunol 125:1216","journal-title":"J Immunol"},{"key":"60370445280_CR24","first-page":"4799","volume":"48","author":"T Priebe","year":"1988","unstructured":"Priebe T, Kandil O, Nakic M, Pan, BF, Nelson JA (1988) Selective modulation of antibody response and natural killer cell activity by purine nucleoside analogues. Cancer Res 48:4799","journal-title":"Cancer Res"},{"key":"60370445280_CR25","first-page":"4328","volume":"50","author":"T Priebe","year":"1990","unstructured":"Priebe T, Platsoucas CD, Nelson JA (1990) Adenosine receptors and modulation of natural killer cell activity by purine nucleosides. Cancer Res 50:4328","journal-title":"Cancer Res"},{"key":"60370445280_CR26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0008-8749(90)90208-9","volume":"129","author":"T Priebe","year":"1990","unstructured":"Priebe T, Platsoucas CD, Seki H, Fox FE, Nelson JA (1990) Purine nucleoside modulation of functions of human lymphocytes. Cell Immunol 129:321","journal-title":"Cell Immunol"},{"key":"60370445280_CR27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0008-8749(90)90291-X","volume":"130","author":"T Priebe","year":"1990","unstructured":"Priebe T, Ruiz L, Nelson JA (1990) Role of natural killer cells in the modulation of primary antibody production by purine nucleosides and their analogues. Cell Immunol 130:513","journal-title":"Cell Immunol"},{"key":"60370445280_CR28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"KR Rai","year":"1975","unstructured":"Rai KR, Sawitsky A, Cronkite EP (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46:219","journal-title":"Blood"},{"key":"60370445280_CR29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1200\/JCO.1992.10.5.790","volume":"10","author":"JR Redman","year":"1992","unstructured":"Redman JR, Cabanillas F, Velasquez WS, McLaughlin P, Hagemeister FB, Swan F, Rodriquez MA, Plunkett WK, Keating, MJ (1992) Phase II trial of fludarabine phosphate in lymphoma: An effective new agent in low grade lymphomas. J Clin Oncol 10:790","journal-title":"J Clin Oncol"},{"key":"60370445280_CR30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood.V80.1.29.29","volume":"80","author":"LE Robertson","year":"1992","unstructured":"Robertson LE, Huh YO, Butler JJ, Pugh WC, Hirsch-Ginsberg C, Stass S, Kantarjian H, Keating MJ (1992) Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: Clinical, pathologic, immunophenotypic, and molecular analysis. Blood 80:29","journal-title":"Blood"},{"key":"60370445280_CR31","first-page":"3147","volume":"35","author":"LE Robertson","year":"1994","unstructured":"Robertson LE, Denny AW, Keating MJ, Huh YO, Plunkett W, Nelson JA (1994) Fludarabine modulation of NK cell activity in chronic lymphocytic leukemia. Proc. Am. Assoc Cancer Res 35:3147","journal-title":"Proc. Am. Assoc Cancer Res"},{"key":"60370445280_CR32","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.4049\/jimmunol.123.5.2174","volume":"5","author":"JC Roder","year":"1979","unstructured":"Roder JC, Lohmann-Matthes M-L, Domzig W, Wigzell H (1979) The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J Immunol 5:2174","journal-title":"J Immunol"},{"key":"60370445280_CR33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.1985.tb27091.x","volume":"451","author":"JE Seegmiller","year":"1985","unstructured":"Seegmiller JE (1985) Overview of possible relation of defects in purine metabolism to immune deficiency. Ann N Y Acad Sci 451:9","journal-title":"Ann N Y Acad Sci"},{"key":"60370445280_CR34","first-page":"547","volume":"6","author":"N Villamor","year":"1992","unstructured":"Villamor N, Reverter J-C, Montserrat E, Urbano-Ispizua A, Vives-Corrons J-L, Rozman C (1992) Recombinant alpha-2b-interferon may restore natural-killer activity in patients with B-chronic lymphocytic leukemia. Leukemia 6:547","journal-title":"Leukemia"},{"key":"60370445280_CR35","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/S0021-9258(18)45884-X","volume":"267","author":"S-W Yang","year":"1992","unstructured":"Yang S-W, Huang P, Plunkett W, Becker FF, Chan YH (1992) Dual mode of inhibition of purified DNA ligase I from human cells by 9-\u03b2-D-arabinofuranosyl-2-fiuoroadenine triphosphate. J Biol Chem 267:2345","journal-title":"J Biol Chem"},{"key":"60370445280_CR36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ijc.2910270310","volume":"27","author":"HW Ziegler","year":"1981","unstructured":"Ziegler HW, Kay NE, Zarling JM (1981) Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia. Int J Cancer 27:321","journal-title":"Int J Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s002800050410.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s002800050410\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s002800050410","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T19:42:35Z","timestamp":1680637355000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s002800050410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,3]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,3]]}},"alternative-id":["60370445280"],"URL":"https:\/\/doi.org\/10.1007\/s002800050410","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,3]]}}}